Stock Analysis on Net

Intuitive Surgical Inc. (NASDAQ:ISRG)

$24.99

Analysis of Solvency Ratios
Quarterly Data

Microsoft Excel

Paying user area


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Solvency Ratios (Summary)

Intuitive Surgical Inc., solvency ratios (quarterly data)

Microsoft Excel
Mar 31, 2026 Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022
Debt Ratios
Debt to equity
Debt to capital
Debt to assets
Financial leverage

Based on: 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).


The solvency profile exhibits a high degree of stability over the observed period from March 2022 through March 2026. A notable absence of values for debt-to-equity, debt-to-capital, and debt-to-assets ratios suggests a minimal reliance on traditional debt financing or a capital structure characterized by very low leverage.

Financial Leverage
The financial leverage ratio remained remarkably consistent, fluctuating within a narrow band between 1.12 and 1.17. A marginal upward trend was observed throughout 2022, peaking at 1.17 in December. Throughout 2023, the ratio remained stable, hovering between 1.16 and 1.17. A slight contraction occurred in the first half of 2024, with the ratio dipping to 1.13. From March 2025 onward, a gradual and steady increase is observed, moving from 1.12 to 1.15 by March 31, 2026. This minimal variance indicates a disciplined and steady approach to asset financing and a low-risk solvency position.

Debt Ratios


Debt to Equity

Intuitive Surgical Inc., debt to equity calculation (quarterly data)

Microsoft Excel
Mar 31, 2026 Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022
Selected Financial Data (US$ in thousands)
Total debt
Total Intuitive Surgical, Inc. stockholders’ equity
Solvency Ratio
Debt to equity1
Benchmarks
Debt to Equity, Competitors2
Abbott Laboratories
Elevance Health Inc.
Medtronic PLC
UnitedHealth Group Inc.

Based on: 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).

1 Q1 2026 Calculation
Debt to equity = Total debt ÷ Total Intuitive Surgical, Inc. stockholders’ equity
= ÷ =

2 Click competitor name to see calculations.


Analysis of the solvency metrics reveals a sustained growth trajectory in stockholders' equity from March 2022 through March 2026. While specific debt figures and resulting debt-to-equity ratios are not recorded, the progression of equity provides significant insight into the capital structure and financial stability of the entity.

Stockholders' Equity Trend
A period of moderate contraction is observed during 2022, where equity decreased from 12,102,300 thousand US$ in March to a minimum of 11,041,900 thousand US$ by December. Following this trough, a consistent upward trend commenced in early 2023. Equity grew steadily through 2023 and 2024, reaching 16,433,700 thousand US$ by the end of 2024. Although a temporary decline occurred in June 2025, the balance recovered to reach 17,474,500 thousand US$ by March 2026, marking an overall increase of approximately 44.4% over the observed period.
Debt to Equity Position
The lack of recorded total debt values renders the calculation of a precise debt-to-equity ratio impossible based on the available information. However, the substantial and expanding base of stockholders' equity indicates a financial strategy characterized by low leverage and a strong reliance on internal funding and retained earnings rather than external debt.

Debt to Capital

Intuitive Surgical Inc., debt to capital calculation (quarterly data)

Microsoft Excel
Mar 31, 2026 Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022
Selected Financial Data (US$ in thousands)
Total debt
Total Intuitive Surgical, Inc. stockholders’ equity
Total capital
Solvency Ratio
Debt to capital1
Benchmarks
Debt to Capital, Competitors2
Abbott Laboratories
Elevance Health Inc.
Medtronic PLC
UnitedHealth Group Inc.

Based on: 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).

1 Q1 2026 Calculation
Debt to capital = Total debt ÷ Total capital
= ÷ =

2 Click competitor name to see calculations.


The solvency profile of the organization is characterized by a complete absence of reported total debt across the observed period from March 2022 through March 2026. This indicates a capital structure funded entirely through equity or other non-debt instruments, resulting in a zero-debt-to-capital ratio.

Total Debt and Solvency
The reported total debt remains nonexistent for all analyzed quarters. This absence of leverage suggests a conservative financial strategy and a minimal risk of insolvency related to debt obligations.
Total Capital Trends
Total capital experienced a period of contraction during 2022, declining from 12.1 billion US dollars in March to 11.0 billion US dollars by December. Following this period, a consistent growth trajectory was observed starting in early 2023, with capital increasing steadily to a peak of 17.8 billion US dollars by June 2025. Subsequent quarters show moderate volatility, with a decrease to 16.9 billion US dollars in September 2025, a recovery to 17.8 billion US dollars in December 2025, and a final slight decline to 17.4 billion US dollars by March 2026.
Debt to Capital Ratio
Due to the absence of debt, the debt-to-capital ratio remains at 0% throughout the entire timeframe. This demonstrates an exceptionally low reliance on borrowed funds relative to the total capital employed by the organization.

Debt to Assets

Intuitive Surgical Inc., debt to assets calculation (quarterly data)

Microsoft Excel
Mar 31, 2026 Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022
Selected Financial Data (US$ in thousands)
Total debt
Total assets
Solvency Ratio
Debt to assets1
Benchmarks
Debt to Assets, Competitors2
Abbott Laboratories
Elevance Health Inc.
Medtronic PLC
UnitedHealth Group Inc.

Based on: 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).

1 Q1 2026 Calculation
Debt to assets = Total debt ÷ Total assets
= ÷ =

2 Click competitor name to see calculations.


The analysis of solvency metrics reveals a consistent expansion of the asset base coupled with a complete absence of recorded total debt throughout the observed period.

Total Assets Trend
A general upward trajectory in total assets is observed, beginning at 13,678,400 thousand US dollars in March 2022 and reaching 20,111,000 thousand US dollars by March 2026. While a marginal decline occurred between June 2022 and December 2022, the asset base experienced sustained growth through 2023 and 2024. The value peaked at 20,458,700 thousand US dollars in December 2025, followed by a slight contraction in the first quarter of 2026.
Solvency and Debt Positioning
Throughout the entire reporting window, total debt is recorded as zero or remains unreported. Consequently, the debt to assets ratio is effectively zero. This indicates a highly conservative capital structure characterized by an absence of leverage, suggesting that asset growth has been funded through internal cash flows or equity rather than borrowed capital.

Financial Leverage

Intuitive Surgical Inc., financial leverage calculation (quarterly data)

Microsoft Excel
Mar 31, 2026 Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022
Selected Financial Data (US$ in thousands)
Total assets
Total Intuitive Surgical, Inc. stockholders’ equity
Solvency Ratio
Financial leverage1
Benchmarks
Financial Leverage, Competitors2
Abbott Laboratories
Elevance Health Inc.
Medtronic PLC
UnitedHealth Group Inc.

Based on: 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).

1 Q1 2026 Calculation
Financial leverage = Total assets ÷ Total Intuitive Surgical, Inc. stockholders’ equity
= ÷ =

2 Click competitor name to see calculations.


The financial position is characterized by a substantial expansion of the resource base and a highly conservative capital structure. Following a brief period of contraction in 2022, both total assets and stockholders' equity exhibited a strong and consistent upward trajectory through early 2026.

Asset and Equity Expansion
Total assets grew from 13.68 billion USD in March 2022 to a peak of 20.46 billion USD in December 2025. This growth was mirrored by stockholders' equity, which increased from 12.10 billion USD in the same starting period to 17.85 billion USD by June 2025. The parallel movement of these two metrics indicates that the increase in assets was primarily financed through equity rather than debt.
Financial Leverage Stability
The financial leverage ratio remained exceptionally stable, fluctuating within a narrow band between 1.12 and 1.17 over the entire period. A slight peak in leverage occurred in December 2022 at 1.17, coinciding with the period of lowest total assets and equity, before trending toward a low of 1.12 by March 2025.
Solvency and Risk Profile
The consistently low leverage ratio suggests a minimal reliance on external borrowing to fund operations and growth. By maintaining a ratio close to 1.1x, the organization demonstrates a strong solvency position with very low financial risk, as the proportion of assets funded by shareholders remains dominant.

Overall, the data reflects a period of disciplined growth. The ability to scale total assets by approximately 47% between March 2022 and December 2025 while keeping financial leverage virtually constant underscores a strategy of organic growth and financial prudence.